FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3092157046> ?p ?o ?g. }

• W3092157046 abstract "Abstract Background The metzincin family of metalloproteinases and the tissue inhibitors of metalloproteinases (TIMPs) are essential proteins required for biological processes during cancer progression. This study aimed to determine the role of TIMP-2 in ovarian cancer progression and chemoresistance by reducing TIMP-2 expression in vitro in Fallopian tube secretory epithelial (FT282) and ovarian cancer (JHOS2 and OVCAR4) cell lines. Methods FT282, JHOS2 and OVCAR4 cells were transiently transfected with either single or pooled TIMP-2 siRNAs. The expression of different genes after TIMP-2 knock down (T2-KD) or in response to chemotherapy was determined at the mRNA level by quantitative real time PCR (qRT-PCR) and at the protein level by immunofluorescence. Sensitivity of the cell lines in response to chemotherapy after TIMP-2 knock down was investigated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and 5-Ethynyl-2′-deoxyuridine (EdU) assays. Cell invasion in response to TIMP-2 knockdown was determined by xCELLigence. Results Sixty to 90 % knock down of TIMP-2 expression was confirmed in FT282, OVCAR4 and JHOS2 cell lines at the mRNA and protein levels. TIMP-2 knock down did not change the mRNA expression of TIMP-1 or TIMP-3. However, a significant downregulation of MMP-2 in T2-KD cells occurred at both the protein and activation levels, compared to Control (Cont; scrambled siRNA) and Parental cells (P, transfection reagent only). In contrast, membrane bound MT1-MMP protein levels were significantly upregulated in T2-KD compared to Cont and P cells. T2-KD cells exhibited enhanced proliferation and increased sensitivity to cisplatin and paclitaxel treatments. Enhanced invasion was observed in the T2-KD-JOSH2 and OVCAR4 cells but not in T2-KD-FT282 cells. Treatment with cisplatin or paclitaxel significantly elevated the expression of TIMP-2 in Cont cells but not in T2-KD cells, consistent with significantly elevated expression of chemoresistance and CSC markers and activation of STAT3. Furthermore, a potent inhibitor of STAT3 activation, Momelotinib, suppressed chemotherapy-induced activation of P-STAT3 in OVCAR4 cells with concomitant reductions in the expression of chemoresistance genes and CSC markers. Conclusions The above results suggest that TIMP-2 may have a novel role in ovarian cancer proliferation, invasion and chemoresistance." @default.
• W3092157046 created "2020-10-15" @default.
• W3092157046 creator A5030904984 @default.
• W3092157046 creator A5035820439 @default.
• W3092157046 creator A5037504084 @default.
• W3092157046 creator A5045883594 @default.
• W3092157046 creator A5075373618 @default.
• W3092157046 creator A5088204119 @default.
• W3092157046 creator A5090327179 @default.
• W3092157046 date "2020-10-06" @default.
• W3092157046 modified "2023-10-16" @default.
• W3092157046 title "TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells" @default.
• W3092157046 cites W1532263300 @default.
• W3092157046 cites W1911599821 @default.
• W3092157046 cites W1943317391 @default.
• W3092157046 cites W1966870353 @default.
• W3092157046 cites W1970851801 @default.
• W3092157046 cites W1973214660 @default.
• W3092157046 cites W1980494624 @default.
• W3092157046 cites W1982268574 @default.
• W3092157046 cites W2001679358 @default.
• W3092157046 cites W2004383233 @default.
• W3092157046 cites W2004611539 @default.
• W3092157046 cites W2008107052 @default.
• W3092157046 cites W2008745393 @default.
• W3092157046 cites W2012582486 @default.
• W3092157046 cites W2014638657 @default.
• W3092157046 cites W2027329004 @default.
• W3092157046 cites W2050394736 @default.
• W3092157046 cites W2051043829 @default.
• W3092157046 cites W2053271495 @default.
• W3092157046 cites W2057059946 @default.
• W3092157046 cites W2059196682 @default.
• W3092157046 cites W2059736531 @default.
• W3092157046 cites W2062165914 @default.
• W3092157046 cites W2066204710 @default.
• W3092157046 cites W2067067209 @default.
• W3092157046 cites W2071359561 @default.
• W3092157046 cites W2071855640 @default.
• W3092157046 cites W2082892212 @default.
• W3092157046 cites W2083882897 @default.
• W3092157046 cites W2085595605 @default.
• W3092157046 cites W2088172329 @default.
• W3092157046 cites W2089818916 @default.
• W3092157046 cites W2091600291 @default.
• W3092157046 cites W2092232185 @default.
• W3092157046 cites W2092743430 @default.
• W3092157046 cites W2100261627 @default.
• W3092157046 cites W2109023646 @default.
• W3092157046 cites W2115094393 @default.
• W3092157046 cites W2116054786 @default.
• W3092157046 cites W2117116694 @default.
• W3092157046 cites W2117402284 @default.
• W3092157046 cites W2125933228 @default.
• W3092157046 cites W2131593373 @default.
• W3092157046 cites W2134540087 @default.
• W3092157046 cites W2136244824 @default.
• W3092157046 cites W2138784667 @default.
• W3092157046 cites W2153602227 @default.
• W3092157046 cites W2155602568 @default.
• W3092157046 cites W2158135562 @default.
• W3092157046 cites W2169850671 @default.
• W3092157046 cites W2327472703 @default.
• W3092157046 cites W2381538464 @default.
• W3092157046 cites W2499438691 @default.
• W3092157046 cites W2753548689 @default.
• W3092157046 cites W2761946249 @default.
• W3092157046 cites W2770300603 @default.
• W3092157046 cites W2788480170 @default.
• W3092157046 cites W2793679179 @default.
• W3092157046 cites W2795330844 @default.
• W3092157046 cites W2897372278 @default.
• W3092157046 cites W2899159263 @default.
• W3092157046 cites W2944434395 @default.
• W3092157046 cites W2967710732 @default.
• W3092157046 cites W3000361261 @default.
• W3092157046 doi "https://doi.org/10.1186/s12885-020-07274-6" @default.
• W3092157046 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7542139" @default.
• W3092157046 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33023532" @default.
• W3092157046 hasPublicationYear "2020" @default.
• W3092157046 type Work @default.
• W3092157046 sameAs 3092157046 @default.
• W3092157046 citedByCount "16" @default.
• W3092157046 countsByYear W30921570462020 @default.
• W3092157046 countsByYear W30921570462021 @default.
• W3092157046 countsByYear W30921570462022 @default.
• W3092157046 countsByYear W30921570462023 @default.
• W3092157046 crossrefType "journal-article" @default.
• W3092157046 hasAuthorship W3092157046A5030904984 @default.
• W3092157046 hasAuthorship W3092157046A5035820439 @default.
• W3092157046 hasAuthorship W3092157046A5037504084 @default.
• W3092157046 hasAuthorship W3092157046A5045883594 @default.
• W3092157046 hasAuthorship W3092157046A5075373618 @default.
• W3092157046 hasAuthorship W3092157046A5088204119 @default.
• W3092157046 hasAuthorship W3092157046A5090327179 @default.
• W3092157046 hasBestOaLocation W30921570461 @default.
• W3092157046 hasConcept C104317684 @default.
• W3092157046 hasConcept C11957725 @default.
• W3092157046 hasConcept C121608353 @default.
• W3092157046 hasConcept C126322002 @default.

• next